Johnson & Johnson is expanding a recall of over-the-counter medicines including Tylenol, Motrin and Benadryl, the company said Thursday.
McNeil Consumer Healthcare, a division of Johnson & Johnson (JNJ, Fortune 500), said it is recalling 21 lots of OTC drugs as a follow-up to a Jan. 15 recall following complaints of a “musty or moldy odor.”
Thursday’s recall includes certain types of Children’s Tylenol as well as adult-strength Benadryl, Motrin IB, Tylenol Extra Strength, Tylenol Day & Night and Tylenol PM.
A McNeil spokeswoman declined to say how many packages are involved in the recall, adding that the company would not provide any further information.
The affected products were stored on a the same type of wooden pallet that contained trace amounts of a chemical that has been linked to the musty odor in the Jan. 15 recall. The risk of serious health problems is remote, McNeil said.
The affected medicines were produced before the January recall, and they were sold in America, Puerto Rico, Fiji, Guatemala, the Dominican Republic, Trinidad and Tobago and Jamaica.